Metastatic duodenal GIST: role of surgery combined with imatinib mesylate - Wikidata - awgldk - TriplyDB

Metastatic duodenal GIST: role of surgery combined with imatinib mesylate

Metastatic duodenal GIST: role of surgery combined with imatinib mesylate

http://www.wikidata.org/entity/Q28221725

about

Gastrointestinal Stromal Tumor-Single-Center Experience with Review of the Literature.Acute bleeding in duodenal gastrointestinal stromal tumor.Clinicopathological features, surgical strategy and prognosis of duodenal gastrointestinal stromal tumors: a series of 300 patients.Surgical treatment of gastrointestinal stromal tumors of the duodenum: a literature review

P2860

Q36408591-D15365CB-26CD-46F1-B2B6-452EA7CAC167 Q38805968-E8A49E4A-D2E4-47D8-8CA0-4F2F7138A0CB Q55247752-01D6274B-D563-4464-8501-FDADDF2483EA Q58553263-15500F9A-9199-41D7-9C06-33B3A321023B

P2860

Metastatic duodenal GIST: role of surgery combined with imatinib mesylate

http://www.wikidata.org/entity/Q28221725

description

2007 nî lūn-bûn

@nan

2007 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մարտին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Metastatic duodenal GIST: role of surgery combined with imatinib mesylate

@ast

Metastatic duodenal GIST: role of surgery combined with imatinib mesylate

@en

Metastatic duodenal GIST: role of surgery combined with imatinib mesylate

@nl

type

label

Metastatic duodenal GIST: role of surgery combined with imatinib mesylate

@ast

Metastatic duodenal GIST: role of surgery combined with imatinib mesylate

@en

Metastatic duodenal GIST: role of surgery combined with imatinib mesylate

@nl

prefLabel

Metastatic duodenal GIST: role of surgery combined with imatinib mesylate

@ast

Metastatic duodenal GIST: role of surgery combined with imatinib mesylate

@en

Metastatic duodenal GIST: role of surgery combined with imatinib mesylate

@nl

P1433

Q28221725-66743D49-8E78-4C0C-9A94-B0839C93859F

P1476

Q28221725-0D8D6D84-DEBA-4F10-9627-DBDA469DAB8D

P2093

Q28221725-04053A60-B42D-4792-BC58-8BCA863BA65E

Q28221725-426EFFD5-73DF-436F-8CC1-090D08C1F21A

Q28221725-8EABCA4C-22DB-4C7F-B04D-5C7CA250B16C

Q28221725-A3486E01-F2C6-43B9-AB88-C9BEF7E71BB0

Q28221725-CF199A60-77B4-4C4F-9CB0-EE23BBFBA92F

P2860

Q28221725-0171D6B6-14DB-45EB-BEDF-A22D47B87F81

Q28221725-12672DA4-4DFD-41D8-9517-033C0303A9DD

Q28221725-2FB9F313-394A-4463-AC57-365F5CFE3B46

Q28221725-37E28BEE-8A6C-4E94-A2AC-D01F64E97CB0

Q28221725-3DD612FE-9A17-4183-B615-E01B9F701B16

Q28221725-4274BC6B-FB8D-4C6B-9E87-D5B01799CA40

Q28221725-948F0998-888E-41F1-8A40-363DB7B25C1E

Q28221725-98C2BD8A-19CD-439A-92C5-90981E83111D

Q28221725-9A06BF30-6A16-4181-97DC-332BFA68DA3A

Q28221725-B9D407E6-F457-4978-A08D-D7F6E1DE66F7

P2888

Q28221725-B1156DD1-CA2C-4B01-8D4A-F0EC1CEAB337

P304

Q28221725-EB62B2E0-81C2-464E-8039-FE0E4A2921A7

P31

Q28221725-400DD17B-1A7D-475C-9317-D6B820DAC70E

P356

Q28221725-247EFFE8-CE56-4E71-B8D6-6ADAC8E3EA18

P407

Q28221725-DE5F67D5-8F6E-405E-AEA6-C9E036D2C3AA

P433

Q28221725-1490504F-AB5C-443E-A68B-5F6D92EFAC29

P478

Q28221725-87A31A69-8D4A-4238-936F-DAD84B3895A0

P577

Q28221725-3A0F1992-B101-4782-9F1E-6AFCEDD77601

P5875

Q28221725-02C49146-619A-4CD1-A327-34B4CC01B825

P6179

Q28221725-AB1D4F61-8BAE-485B-8545-E6B5EA22B4A1

P698

Q28221725-E94C28B0-BDB7-49AE-BB9D-D3D079F150CA

P932

Q28221725-5B43D518-EF52-4E02-A6E6-524815294B93

P356

P1433

International Seminars in Surgical Oncology

P1476

Metastatic duodenal GIST: role of surgery combined with imatinib mesylate

@en

P2093

Asma Munir

http://www.w3.org/2001/XMLSchema#string

Breda Memon

http://www.w3.org/2001/XMLSchema#string

Kamran Mohiuddin

http://www.w3.org/2001/XMLSchema#string

Muhammed A Memon

http://www.w3.org/2001/XMLSchema#string

Saira Nizami

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.

Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

Clinical management of gastrointestinal stromal tumors: before and after STI-571.

Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review.

Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal.

Clinical presentation of gastrointestinal stromal tumors and treatment of operable disease.

Overview of issues related to imatinib therapy of advanced gastrointestinal stromal tumors: a discussion among the experts.

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study.

Gastrointestinal stromal tumors: a spectrum of disease.

P2888

P304

9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1477-7800-4-9

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2007-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6417707

http://www.w3.org/2001/XMLSchema#string

P6179

1045253062

http://www.w3.org/2001/XMLSchema#string

P698

17391535

http://www.w3.org/2001/XMLSchema#string

P932

1851968

http://www.w3.org/2001/XMLSchema#string